Cabrera Alessandra E, Kimberly Laura L, Kantar Rami S, Atamian Elisa K, Manjunath Amit K, Rangel Lauren K, McQuinn Michelle W, Diaz-Siso J Rodrigo, Rodriguez Eduardo D
Hansjörg Wyss Department of Plastic Surgery.
Division of Medical Ethics, New York University Langone Health, New York, NY.
J Craniofac Surg. 2018 Jun;29(4):848-851. doi: 10.1097/SCS.0000000000004633.
Facial transplantation (FT) has attracted the interest of individuals with facial disfigurement as a path to social reintegration. The perception among face transplant recipients and the reconstructive surgery community appears to be that superior functional and esthetic outcomes can be obtained with FT compared to autologous reconstruction (AR). Although lifelong immunosuppression adds well-known risks to FT, its benefits have proven difficult to quantify, especially because of its non-life-saving nature. Evidence that the general public perceives facial allograft recipients as less disfigured than AR patients may dramatically alter the currently accepted risk/benefit ratio of this novel procedure. A survey containing independent images of individuals in nondisfigured (ND), autologous facial reconstruction, and FT groups was administered to the general public in an urban environment. Participants assigned a disfigurement score to each photograph using the Observer-Rated Facial Disfigurement Scale, a validated instrument used to rate facial disfigurement among head and neck cancer patients. One-way analysis of variance was used to calculate differences in mean level of perceived facial disfigurement among the 3 groups. A total of 250 participants completed the survey. Mean perceived disfigurement scores assigned to the ND, FT, and AR groups were 1.2 ± 0.4, 4.9 ± 1.3, and 8.5 ± 0.6, respectively. A significant difference in disfigurement score was observed between all 3 groups (P < 0.001). This pilot study suggests that the general public perceives the esthetic outcome of FT to be superior to those obtained with AR in patients with severe facial defects.
面部移植(FT)作为一种实现社会重新融入的途径,已引起面部毁容者的关注。面部移植受者和重建外科界的看法似乎是,与自体重建(AR)相比,面部移植能获得更好的功能和美学效果。尽管终身免疫抑制给面部移植带来了众所周知的风险,但其益处却难以量化,尤其是因其并非挽救生命的性质。有证据表明,公众认为面部同种异体移植受者的毁容程度低于自体重建患者,这可能会显著改变这种新手术目前公认的风险/收益比。在城市环境中,对普通公众进行了一项调查,调查内容包含无面部缺陷(ND)者、自体面部重建者和面部移植者的独立图像。参与者使用观察者评定面部毁容量表为每张照片评定毁容分数,该量表是一种经过验证的工具,用于对头颈部癌症患者的面部毁容进行评分。采用单因素方差分析来计算三组之间面部毁容平均感知水平的差异。共有250名参与者完成了调查。ND组、面部移植组和自体重建组的平均毁容感知分数分别为1.2±0.4、4.9±1.3和8.5±0.6。三组之间的毁容分数存在显著差异(P<0.001)。这项初步研究表明,普通公众认为面部移植的美学效果优于严重面部缺陷患者的自体重建效果。